Alloreactivity after transplantation is associated with profound immune suppression, and consequent opportunistic infection results in high morbidity and mortality. This immune suppression is most profound during GVHD after bone marrow transplantation where an inflammatory cytokine storm dominates. Contrary to current dogma, which avers that this is a T-cell defect, we demonstrate that the impairment lies within conventional dendritic cells (cDCs). Significantly, exogenous antigens can only be presented by the CD8(-) cDC subset after bone marrow transplantation, and inflammation during GVHD specifically renders the MHC class II presentation pathway in this population incompetent. In contrast, both classic and cross-presentation within MHC c...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subs...
Chronic graft-versus-host disease (cGVHD) is a major cause of late mortality following allogeneic bo...
Chronic graft-versus-host disease (cGVHD) is a major cause of late mortality following allogeneic bo...
The role of Ag presenting cell subsets in graft-versus-host disease (GVHD) remains unclear. We have ...
Viral infection is a common, life-threatening complication after allogeneic bone marrow transplantat...
Allogeneic bone marrow transplantation (BMT) is utilised as a curative therapy for haematological ma...
AbstractGraft-versus-host disease (GVHD) causes significant morbidity and mortality in patients unde...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
Alloreactivity after transplantation is associated with profound immune suppression, and consequent ...
Immune insufficiency during GVHD is due to defective antigen presentation within dendritic cell subs...
Chronic graft-versus-host disease (cGVHD) is a major cause of late mortality following allogeneic bo...
Chronic graft-versus-host disease (cGVHD) is a major cause of late mortality following allogeneic bo...
The role of Ag presenting cell subsets in graft-versus-host disease (GVHD) remains unclear. We have ...
Viral infection is a common, life-threatening complication after allogeneic bone marrow transplantat...
Allogeneic bone marrow transplantation (BMT) is utilised as a curative therapy for haematological ma...
AbstractGraft-versus-host disease (GVHD) causes significant morbidity and mortality in patients unde...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
According to the self-nonself model of immunity, allogeneic T cells are considered as major cause of...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...
International audienceThe wider use of allogeneic stem cell transplantation (allo-SCT) is still limi...